title: Tumor lysis syndrome and acquired ichthyosis occurring after chemotherapy for lung adenocarcinoma.
authors: Kyorin University School of Medicine, Mitaka City, Tokyo, Japan. h510@ks.kyorin-u.ac.jp
authors: Kojiro
authors: K
authors: Honda
authors: Takeshi
authors: T
authors: Saraya
authors: Masaki
authors: M
authors: Tamura
authors: Takuma
authors: T
authors: Yokoyama
authors: Masachika
authors: M
authors: Fujiwara
authors: Hajime
authors: H
authors: Goto
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007057:Ichthyosis / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016190:Carboplatin